Biomedical Engineering Reference
In-Depth Information
the conduction of electrons in crystalline solids. This periodicity strengthened by
Bloch state, significantly enhances the detection capability by fine-tuning several
parameters for the photonic crystal. According to Bloch state, the energy eigenval-
ues can be depicted as below:
 
ε
()
k
=
ε
(
kK
+
)
n
n
where K stands for periodicity of the reciprocal lattice vector (Fig. 11.12 ).
The unique eigen-states become very effective in resonance mode. The reso-
nance mode can be modulated when refractive indices of the surrounding environ-
ments changes or the analyte is absorbed on a sensing surface, by changing the
resonance condition of the Fabry-Perot microcavity:
2
π
2
nd
cos
θα π
+= +
(2
m
1)
where
(
m
=
0,1, 2,....)
λ
α stands for the Goos-Hänchen phase shift between sensing surface and bulk envi-
ronmen, θ for the incident angle of the beam, n for the refractive index.
Because of its extreme sensitivity, it has been used to build a general-purpose
platform for label-free and fluorescent assays [ 121 - 123 ]. The Cunningham research
laboratory develops a method to investigate alterations of cell adhesion induced
on photonic crystal sensors by exposing them to drugs with selective activation of
a sub-class GPCR. Schematics of commercial photonic crystal product and their
mechanisms are shown in Fig. 11.11 . BIND® (SRU Biosystems) employs photonic
crystal structures to provide sensitive measurements of changes in binding or adher-
ence adjacent to the BIND Biosensor surface. These biosensors incorporate a novel
nanostructured optical grating which reflects a narrow range of wavelengths of il-
luminating light with broadband light. BIND is able to test numerous biomolecular
interactions including receptor activation, cell adhesion, protein-protein binding
and so forth. Specifically, they have demonstrated a GPCR subtype (G i , G q , G s ,
G 12/13 coupled) activation based on a variety of cellular responses including calcium
mobilization, β-arrestin localization or second messenger levels.
Corning Corporation have also developed an EPIC® system for a high-through-
put label-free screening platform based on optical biosensor technology [ 120 ].
Numerous applications on cell-based GPCR assays can be found [ 124 - 126 ] and
compared to other label-free detection methodologies to provide interesting side-
to-side evaluation [ 127 , 128 ]. Fang et al. organized a list of publications regard-
ing a label-free optical biosensor utilizing resonant waveguide gating for whole
cell GPCR assays [ 129 , 130 ]. These optical waveguide structures are fabricated
by technologies based on microelectromechanical systems (MEMS); therefore it
can be easily integrated with microfluidics for precise analyte controls over the
optical waveguide. Many types of the microfluidic and nanofluidic systems have
shown its compatibility with a variety of MEMS (i.e. electrochemical pump [ 131 ],
microheater [ 132 ], NEMS resonator [ 133 ] etc.). In addition, a wide range of these
micro and nanofluidic system (down to few nanometer [ 88 ]) will allow the same
scale analysis of analytes incorporated onto this optical waveguide or any MEMS
Search WWH ::




Custom Search